<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
  <akn:act name="dc-code">
    <akn:meta>
      <akn:identification source="#cosilico">
        <akn:FRBRWork>
          <akn:FRBRuri value="/akn/us-dc/code/1-620.34"/>
          <akn:FRBRdate date="2025-12-31" name="retrieval"/>
          <akn:FRBRauthor href="#dc-council"/>
          <akn:FRBRcountry value="us-dc"/>
        </akn:FRBRWork>
        <akn:FRBRExpression>
          <akn:FRBRuri value="/akn/us-dc/code/1-620.34/eng@2025"/>
          <akn:FRBRdate date="2025-12-31"/>
          <akn:FRBRauthor href="#cosilico"/>
          <akn:FRBRlanguage language="en"/>
        </akn:FRBRExpression>
      </akn:identification>
    </akn:meta>
    <akn:body>
      <akn:section eId="sec_1_620_34">
        <akn:num>1-620.34</akn:num>
        <akn:heading>Testing methodology.</akn:heading>
<akn:subsection eId="subsec_1-620_34_a">
      <akn:num>(a)</akn:num>
      <akn:content><akn:p>Testing shall be performed by an outside contractor at a laboratory certified by the United States Department of Health and Human Services (“HHS”) to perform job-related drug and alcohol forensic testing.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_1-620_34_b">
      <akn:num>(b)</akn:num>
      <akn:content><akn:p>For random testing of District employees, the contractor shall, at a location designated by the District to collect urine specimens on-site, split each sample and perform enzyme-multiplied-immunossay technique (“EMIT”) testing on one sample and store the split of that sample. Any positive EMIT test shall be then confirmed by the contractor, using the gas chromatography/mass spectrometry (“GCMS”) methodology.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_1-620_34_c">
      <akn:num>(c)</akn:num>
      <akn:content><akn:p>Any District employee found to have a confirmed positive urinalysis shall be notified of the result. The employee may then authorize that the stored sample be sent to another HHS-certified laboratory of his or her choice, at his or her expense, for a confirmation, using the GCMS testing method.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_1-620_34_d">
      <akn:num>(d)</akn:num>
      <akn:content><akn:p>Reasonable suspicion and post-accident employee testing shall follow the same procedures set forth in subsections (a) through (c) of this section. In such cases, the employee shall be escorted by a supervisor to the contractor’s test site for specimen collection or a breathalyser.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_1-620_34_e">
      <akn:num>(e)</akn:num>
      <akn:content><akn:p>A breathalyser shall be deemed positive by the District’s testing contractor if the contractor determines that 1 milliliter of the employee’s breath (consisting of substantially alveolar air) contains .38 micrograms or more of alcohol.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_1-620_34_f">
      <akn:num>(f)</akn:num>
      <akn:content><akn:p>Prior to testing, a physician must sit down with the employee and ask what medications he or she might have been taking to rule out any false positives in the drug screening results.</akn:p></akn:content>
    </akn:subsection>
      </akn:section>
    </akn:body>
  </akn:act>
</akn:akomaNtoso>
